Earnings calls

Shilpa Medicare concall ledger

Every earnings call for SHILPAMED — management tone, guidance, KPIs and promise tracking, quarter by quarter.

SHILPAMED · 5 transcripts · Healthcare · latest Q4 FY26

Q4 FY26Published 22 May 2026Call held 22 May 2026

SHILPAMED Q4 FY26 Earnings Call Transcript & Analysis

Revenue₹439 cr+30% YoYEBITDA₹121 cr+40% YoYEBITDA Margin28%Adjusted PAT₹87 crNet Debt₹613 cr

Revenue (Q4 FY26) ₹439 cr (+30% YoY); EBITDA (Q4 FY26) ₹121 cr (+40% YoY); EBITDA Margin (Q4 FY26) 28.0%. Highest ever quarterly revenue of ₹439 crores, up 30% YoY.

Read full transcript & analysis

Q3 FY26Published 06 Feb 2026Call held 06 Feb 2026

SHILPAMED Q3 FY26 Earnings Call Transcript & Analysis

Revenue₹411 cr+28% YoYEBITDA₹115 cr+41% YoYEBITDA Margin28%+2% YoYPAT₹55 crAdjusted ROCE17%

Revenue ₹411 cr (+28% YoY); EBITDA ₹115 cr (+41% YoY); EBITDA Margin 28% (+2% YoY). Revenue of ₹411 crores, up 28% YoY.

Read full transcript & analysis

Q2 FY26Published 17 Nov 2025Call held 17 Nov 2025

SHILPAMED Q2 FY26 Earnings Call Transcript & Analysis

Revenue₹372 cr+7% YoYEBITDA₹110 cr+21% YoYEBITDA Margin30%+4% YoYPAT₹44 crGross Margin72%

Revenue ₹372 cr (+7% YoY); EBITDA ₹110 cr (+21% YoY); EBITDA Margin 30% (+4% YoY). Highest ever quarterly EBITDA of ₹110 crores, up 21% YoY.

Read full transcript & analysis

Q1 FY26Published 13 Aug 2025Call held 13 Aug 2025

SHILPAMED Q1 FY26 Earnings Call Transcript & Analysis

Revenue₹328 cr+9% YoYEBITDA₹98 cr+18% YoYEBITDA Margin30%Gross Margin76%

Revenue ₹328 cr (+9% YoY); EBITDA ₹98 cr (+18% YoY); EBITDA Margin 30%. Revenue of ₹328 crores, up 9% YoY.

Read full transcript & analysis

Q4 FY25Published 26 May 2025Call held 26 May 2025

SHILPAMED Q4 FY25 Earnings Call Transcript & Analysis

Revenue₹338 cr+15% YoYEBITDA₹84 cr+15% YoYEBITDA Margin25%Adjusted PAT₹97 cr+250% YoYGross Margin69%

Revenue ₹338 cr (+15% YoY); EBITDA ₹84 cr (+15% YoY); EBITDA Margin 25%. Revenue of ₹338 crores, up 15% YoY in Q4 FY25.

Read full transcript & analysis